Iovance Biotherapeutics Inc Annual Shareholders Meeting Transcript
Good morning. Will the meeting please come to order. My name is Iain Dukes, and I am the Chairman of the Board of Directors of Iovance Biotherapeutics, Inc. I'm pleased to welcome all of you to this annual meeting of the stockholders of Iovance Biotherapeutics.
In light of the public health impact of the coronavirus outbreak and in order to help protect the health and well-being of our shareholders and employees, this meeting is being held virtually through a live webcast. I would like to introduce you to Iovance directors and officers who are attending today's meeting: Maria Fardis; Athena Countouriotis; Ryan Maynard; Merrill A. McPeak; Wayne P. Rothbaum; and Michael Weiser are all directors of the company. Dr. Fardis is also the company's President and Chief Executive Officer.
Two of our other officers, Timothy Morris, our Chief Financial Officer; and Fred Vogt, our General Counsel, are also in attendance. Also present is Alan Markowitz, a representative of Marcum LLP, the company's independent registered public
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |